Abstract
Box–Behnken designs (BBDs) are the very efficient response surface design which provides information exclusively on the effect of experiment variables and overall experimental error in a minimum number of required runs. These designs possess very good symmetry and rotatability and also produce minimal experimental runs, as compared to the popular CCD and deliver maximal information. As a response surface design, BBD requires three levels (−1, 0, 1) and can be applicable for number of factors ranging between 3 and 21. It is possible to use both numerical and categorical factors for optimization in a BBD, but use of categorical factors tends to increase the number of runs. Due to high resolution of CCDs, these can be efficiently useful for a variety of drug product and process optimization. This chapter provides complete details regarding the application of BBD in pharmaceutical drug product development and optimization.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Beg S, Swain S, Rahman M, Hasnain MS, Imam SS (2019) Application of design of experiments (DoE) in pharmaceutical product and process optimization. In: Beg S, Hasnain MS (eds) Pharmaceutical quality by design. Academic Press, New York, pp 43–64
Singh B, Raza K, Beg S (2013) Developing “optimized” drug products employing “designed” experiments. Chem Industry Digest 23:70–76
Beg S, Rahman M, Robaian MA, Alruwaili NK, Imam SS, Panda SK (2020) Pharmaceutical drug product development and process optimization: effective use of quality by design. CRC Press, New York
Beg S, Hasnain MS (2019) Pharmaceutical quality by design: principles and applications. Academic Press, New York
Singh B, Beg S (2013) Quality by design in product development life cycle. Chronicle Pharmabiz 22:72–79
Beg S, Hasnain MS, Rahman M, Swain S (2019) Introduction to quality by design (QbD): fundamentals, principles, and applications. In: Beg S, Hasnain MS (eds) Pharmaceutical quality by design. Academic Press, New York, pp 1–17
Myers RH, Montgomery DC (1995) Response surface methodology: process and product in optimization using designed experiments. Wiley, New York
Beg S, Rahman M, Panda SS (2017) Pharmaceutical QbD: omnipresence in the product development lifecycle. European Pharmaceut Rev 22(1):58–64
Alam N, Beg S, Rizwan M, Ahmad A, Ahmad FJ, Ali A, Aqil M (2015) Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability. Drug Dev Ind Pharm 41(4):692–702
Beg S, Swain S, Gahoi S, Kohli K (2012) Design, development and evaluation of chronomodulated drug delivery Systems of amoxicillin trihydrate with enhanced antimicrobial activity. Curr Drug Deliv 10(2):174–187
Palamakula A, Nutan MTH, Khan MA (2004) Response surface methodology for optimization and characterization of limonene-based coenzyme Q10 self-nanoemulsified capsule dosage form. AAPS PharmSciTech 5(4):114–121
Bansal S, Beg S, Asthana A, Garg B, Asthana GS, Kapil R, Singh B (2016) QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride. Drug Deliv 23(2):437–451
Swain S, Behera UA, Beg S, Sruti J, Patro CN, Dinda SC, Rao ME (2013) Design and characterization of enteric-coated controlled release mucoadhesive microcapsules of rabeprazole sodium. Drug Dev Ind Pharm 39:548–560
Gonzalez-Rodriguez ML, Barros LB, Palma J, Gonzalez-Rodriguez PL, Rabasco AM (2007) Application of statistical experimental design to study the formulation variables influencing the coating process of lidocaine liposomes. Int J Pharm 337(1–2):336–345
Garg BJ, Garg NK, Beg S, Singh B, Katare OP (2016) Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment. J Drug Target 24:233–246
Shah MK, Madan P, Lin S (2013) Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration. Pharmacoeconomics 19(4):475–485
Hasnain MS, Javed MN, Alam MS, Rishishwar P, Rishishwar S, Ali S, Nayak AK, Beg S (2019) Purple heart plant leaves extract-mediated silver nanoparticle synthesis: optimization by Box-Behnken design. Mater Sci Eng 99:1105–1114
Beg S, Saini S, Bandopadhyay S, Katare OP, Singh B (2017) QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques. Drug Dev Ind Pharm 44(3):407–420
Beg S, Choudhry H, Zamzami MA, Alharbi KS, Rahman M, Singh B (2018) Nanocolloidal lipidic carriers of olmesartan medoxomil surface-tailored with Concanavalin-A for lectin receptor targeting. Nanomedicine 13(24):3107–3128
Beg S, Panda SS, Katare OP, Singh B (2017) Applications of Monte-Carlo simulation and chemometric techniques for development of bioanalytical liquid chromatography method for estimation of rosuvastatin calcium. J Liq Chromatogr Relat Technol 40:18
Poonia N, Kaur Narang J, Lather V, Beg S, Sharma T, Singh B, Pandita D (2019) Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: systematic development, characterization and pharmacokinetic evaluation. Colloids Surf B: Biointerfaces 181:756–766
Rahman M, Al-Ghamdi SA, Alharbi KS, Beg S, Sharma K, Anwar F, Al-Abbasi FA, Kumar V (2019) Ganoderic acid loaded nano-lipidic carriers improvise treatment of hepatocellular carcinoma. Drug Deliv 26(1):782–793
Qadir A, Aqil M, Ali A, Warsi MH, Mujeeb M, Ahmad FJ, Ahmad S, Beg S (2020) Nanostructured lipidic carriers for dual drug delivery in the management of psoriasis: systematic optimization, dermatokinetic and preclinical evaluation. J Drug Deliv Sci Technol 57:101775
Beg S, Swain S, Singh HP, Patra CN, Rao MEB (2012) Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers. AAPS PharmSciTech 13(4):1416–1427
Beg S, Jena SS, Patra CN, Rizwan M, Swain S, Sruti J, Rao MEB, Singh B (2013) Development of solid self-nanoemulsifying granules (SSNEGs) of ondansetron hydrochloride with enhanced bioavailability potential. Colloids Surf B: Biointerfaces 101:414–423
Harshita MA, Barkat M, Rizwanullah S, Beg FH, Pottoo SS, Ahmad FJ (2019) Paclitaxel-loaded nanolipidic carriers with improved Oral bioavailability and anticancer activity against human liver carcinoma. AAPS PharmSciTech 20(2):87
Sandhu PS, Beg S, Mehta F, Singh B, Trivedi P (2015) Novel dietary lipid-based self-nanoemulsifying drug delivery systems of paclitaxel with p-gp inhibitor: implications on cytotoxicity and biopharmaceutical performance. Expert Opin Drug Deliv 12(11):1809–1822
Leal-Cruz AL, Berman-Mendoza D, Vera-Marquina A, García-Juárez A, VillaVelazquez-Mendoza C, Zaldívar-Huerta IE (2013) Synthesis and characterization of CBD-CdS nanospheres. IEEE 978(1):4673–6155
Barkat MA, Harshita AI, Ali R, Singh SP, Pottoo FH, Beg S, FJ A (2017) Nanosuspension-based Aloe vera gel of silver sulfadiazine with improved wound healing activity. AAPS PharmSciTech 18:3274–3285
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Beg, S., Akhter, S. (2021). Box–Behnken Designs and Their Applications in Pharmaceutical Product Development. In: Beg, S. (eds) Design of Experiments for Pharmaceutical Product Development. Springer, Singapore. https://doi.org/10.1007/978-981-33-4717-5_7
Download citation
DOI: https://doi.org/10.1007/978-981-33-4717-5_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-4716-8
Online ISBN: 978-981-33-4717-5
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)